Stand Up Therapeutics is intended to treat paralyzed patients caused by spinal cord injury by using Direct lineage Reprogramming technology. It is meaningful in treating paralysis patients caused by spinal cord injury and cerebral damage that relieves the pain of mild and severe patients of around 1% of the world's population.
We plan to expand the pipeline by development of Direct lineage Reprogramming technology through research and develop safe and efficient Direct lineage Reprogramming methods and gene therapy.
We carry out a Contract Research Organization (CRO) project based on the skills of our experienced researchers. In addition, we provides electorphysiological and pathological analysis after creating various cranial nerve disease models according to customer requests and conducting efficacy and safety evaluation tests on the models.